FDA
approval
· 2022-04-29
FDA Approved: JOLESSA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
The FDA approved a supplemental application for JOLESSA (LEVONORGESTREL / ETHINYL ESTRADIOL) from Teva Pharmaceuticals USA, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for JOLESSA (LEVONORGESTREL / ETHINYL ESTRADIOL)